NCT01695174View on ClinicalTrials.gov

A Pilot Study of Xifaxan to Treat Patients With PSC

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Primary Sclerosing Cholangitis (PSC)
Interventions
DRUG

Xifaxan

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01695174 - A Pilot Study of Xifaxan to Treat Patients With PSC | Biotech Hunter | Biotech Hunter